In theory, FIR therapy can reduce intimal hyperplasia, prevent venous stenosis, and increase access flow of the AVF in HD patients via PI3K/Akt-activated NO generation, and is also a potential remedy for other vascular disorders such as peripheral obstructive arterial disease. Here, AKT1 is linked to Huntington disease.